Conference Call Scheduled for 4:30 pm Eastern Time on May 9th
NASDAQ, TSX: NVCN
VANCOUVER, May 3, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") NVCN NVCN, a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it will report financial results for the quarter ended March 31, 2019 and host a conference call and webcast at 4:30 pm Eastern Time on Thursday, May 9, 2019.
Conference Call & Webcast | |
Domestic: | 877-407-9208 |
International: | 201-493-6784 |
Passcode: | 13689510 |
Webcast: |
A replay of the event will be available via webcast through August 9st on the Company's website, www.neovasc.com, or at http://public.viavid.com/index.php?id=133943.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara™, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada and Europe. For more information, visit: www.neovasc.com.
View original content:http://www.prnewswire.com/news-releases/neovasc-to-announce-first-quarter-2019-financial-results-on-thursday-may-9th-300843366.html
SOURCE Neovasc Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.